MINERVAX ApS: Financial statements 2025
CVR: 32673287
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
MINERVAX ApS (CVR 32673287) has filed annual accounts for 2025. In 2025, the company reported a net result of EUR -31,530,000 compared with EUR -29,126,000 the year before. Equity in the 2025 report amounted to EUR 9,787,000. The solvency ratio was 21.4%. The company had 70 employees in the financial year.
- Profit/Loss
- EUR -31,530,000
- Equity
- EUR 9,787,000
- Total Assets
- EUR 45,836,000
- Employees
- 70
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | - | -31.5 mio. EUR | 9.8 mio. EUR | 70 |
| 2024 | - | - | -29.1 mio. EUR | 39.8 mio. EUR | 53 |
| 2023 | - | - | -27.1 mio. EUR | 67.6 mio. EUR | - |
| 2022 | - | -98.2 mio. | -108 mio. | 304.7 mio. | 7 |
| 2021 | - | -57.8 mio. | -61.9 mio. | 98.7 mio. | 7 |
Official annual report
How creditworthy is MINERVAX ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
MINERVAX ApS has published its annual report for 2024. The net result was DKK -29,126,000.
As of April 30, 2025, Varun Kumar Gupta has joined the board of directors of MINERVAX ApS.
As of April 30, 2025, Regina Hodits has left the board of directors of MINERVAX ApS.
About MINERVAX ApS
MINERVAX ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The board consists of Veronica Gambillara Fonck (chair), Bita Sehat, Christopher J. Gagliardi and Emmanuelle Coutanceau. The company's owners include Novo Holdings A/S, SUNSTONE LIFE SCIENCE VENTURES FUND III K/S and Wellington Partners Life Sciences V GmbH & Co. KG. The company has 28 employees (2026). In 2025, the company reported a net result of EUR -31,530,000 compared with EUR -29,126,000 the year before. Equity in the 2025 report amounted to EUR 9,787,000.